A 52-year-old female underwent autologous BMT because of acute myeloid leukaemia FAB M4 in second remission. Since the patient had no HLA-identical sibling she received a purged autologous BM transplant. On day +5 she developed signs of a sepsis syndrome with fluid retention and was treated with broad-spectrum antibiotic therapy. However, her body weight remained high, ascites and an increase of total serum bilirubin and alkaline phosphatase developed. The icterus worsened to a total bilirubin level of 25 mg/100 ml. Sonographic and endoscopic imaging showed a dilated gall bladder but disclosed a post-hepatic cause for the icterus. A transjugular liver biopsy on day +71 revealed severe cholestasis and siderosis. The patient remained aplastic with constantly increased bilirubin levels. On day +73 septic shock syndrome occurred and the patient died of multiorgan failure 3 days later. At autopsy, a highly differentiated bile duct adenocarcinoma at the porta hepatis, so-called Klatskin tumour, was found, explaining the fatal course with intractable cholestasis. Keywords: hepatic VOD; cholestasis; bile duct adenocarcinoma Hepatic veno-occlusive disease (VOD) is a syndrome consisting of weight gain, ascites, increase of bilirubin level, and right upper abdominal quadrant pain with a high rate of lethality. Occasionally it can be accompanied by refractoriness to platelet transfusion. In most cases VOD occurs after allogeneic BMT, and occasionally after high-dose chemotherapy with or without autologous stem cell rescue. Despite a range of prophylactic and therapeutic approaches with administration of heparin and tissue plasminogen activator (tPA), 1 transjugular intrahepatic portosystemic stent- shunt (TIPS) 2-4 and even liver transplantation 5 the prognosis has remained poor.
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We describe a patient who presented clinically with the signs of severe VOD after autologous BMT for AML with an atypical chronic course and a surprising diagnosis post mortem.
Case report
A 52-year-old female patient was referred to our department for BMT. She had AML FAB M4 in second remission. The disease had been diagnosed 16 months earlier and the patient had received induction therapy consisting of DNR, vepeside and Ara-C. Complete remission was achieved. Consolidation therapy with Ara-C followed. Two months after the third consolidation cycle the patient had a relapse. She received reinduction therapy with idarubicin and Ara-C and one course of consolidation therapy prior to BMT. Because the patient had no HLA-identical sibling, autologous BM for transplantation was harvested in second remission 2 months before BMT. The BM was purged by mafosfamide. The CD34 + count after purging was 1.44 × 10 6 /kg. On admission for autologous BMT the patient presented with a Karnofsky score of 100. Clinical examination revealed no pathologic findings. The liver and kidney function was normal.
Conditioning consisted of BU 4 mg/kg orally daily divided into four doses, total dose 16 mg/kg and vepeside 60 mg/kg. The patient tolerated the conditioning regimen well. She was hospitalised in a laminar air flow room. For intestinal decontamination vancomycin and paromomycin were given orally.
Beginning on day +4 after BMT the patient developed oral mucositis. From day +7 the body weight (BW) started to increase up to 24 % over the baseline BW on day +32. On day +8 diarrhoea began and fever of 38.7°C developed despite antibiotic treatment. Bilirubin started to rise on day +12, when it was 1.16 mg/dl, followed by an increase of ␥GT on day +13 and alkaline phosphatase on day +16. The ASAT and ALAT began to rise on day +18. With the rise of bilirubin the patient received dopamine 2 g/kg/min and the haemoglobin was held above 10 g/100 ml.
Tests for occult blood in the stool were negative, blood and stool cultures showed no bacterial or fungal growth at that time, and the chest X-ray was normal. Empirical therapy with amphotericin B was begun on day +8. After symptomatic treatment with loperamide the diarrhoea stopped on day +11. Consecutively, the signs of a paralytic ileus accompanied by a capillary leak syndrome became evident.
An abdominal computed tomography (CT) was performed on day +23. A dilatation of the oesophagus, stomach and the whole intestines, which were filled with fluid, as well as a marked dilatation of the intra-and extrahepatic bile ducts and gall bladder, without signs of a concretion were found. The liver was slightly enlarged and ascites were present. At that time the patient was still aplastic and the serum bilirubin was 9.38 mg/dl. Ultrasonography (US) on days +25 and +39 excluded a concretion as the cause of the icterus. Both investigations revealed moderate hepatomegaly and ascites. On day +28 the patient reported pain in the right upper abdominal quadrant. Acalculous cholecystitis resulting from the parenteral nutrition was diagnosed and enteral nutrition with highcaloric solutions was started. Nevertheless, bilirubin, alkaline phosphatase, and ␥GT increased to peak levels of 23.2 mg/dl, 695 IU/l, and 368 IU/l, respectively, around day +30. ASAT and ALAT peaked at 180 U/l at day +42. Renal function remained normal.
On day +32 the increase of body weight was to 127% compared to baseline weight. Consecutively, the weight almost returned to the day 0 value and remained stable until day +55 when it increased again. On day +61 an endoscopic retrograde cholangiopancreatography (ERCP) was performed. Again, apart from wide bile ducts no abnormalities were demonstrated (Figure 1) . A transjugular liver biopsy on day +62 revealed severe cholestasis and siderosis, but no evidence of malignancy and VOD.
The patient's leucocyte count on day +62 was 480/l. A marrow biopsy specimen on the same day showed rare granulopoesis and a lack of erythro-and megakaryopoesis with no increase of blast cells.
The patient's condition deteriorated rapidly around day +70. A sepsis syndrome developed and within 3 days multiorgan failure occurred and the patient eventually died on day +76. At autopsy, the liver was an intense green and slightly enlarged. Gross examination revealed no evident tumour infiltration but a suspicious small fibrous nodule about 2 cm in diameter. Microscopically, the nodule turned out to be an infiltrating, moderately differentiated adenocarcinoma of the large bile ducts, so-called Klatskin tumour (Figure 2 ). There was neither leukaemic infiltration nor evidence of VOD.
Discussion
Despite a range of imaging methods as well as invasive means, jaundice and impaired liver function following BMT can cause severe diagnostic problems, as demonstrated by this case. The symptoms of right upper abdominal pain, ascites, and weight gain accompanied by increasing bilirubin levels and refractoriness to platelet transfusions were consistent with VOD. On the other hand, the markedly elevated ratio of direct/indirect bilirubin and alkaline phosphatase suggested a post-hepatic cause of the icterus.
However, on CT the bile ducts presented a markedly dilated appearance but a bile concretion was excluded. Consecutive ultrasonography showed the intestinal walls were swollen and the gall bladder walls were markedly thickened. Although the latter finding has been observed in patients with VOD, 6 the dilatation of the extrahepatic bile ducts and the icterus were interpreted to be due to a functional stenosis of the Papilla Vateri caused by the generalised intestinal mucosal oedema.
When the intestinal problems had resolved but the icterus worsened further, acalculous cholecystitis was presumed to be the underlying cause. This disease occurs infrequently in intensive care patients with long-term parenteral nutrition as a risk factor 7 and has been described in bone marrow transplant recipients. 8 The treatment consists of switching to enteral nutrition and surgery in selected cases. However, the icterus did not ameliorate despite the patient receiving nutrition orally from that point but the pain resolved.
More invasive procedures were chosen because of the persisting icterus and increase of the alkaline phosphatase. In most cases of post-hepatic icterus ERCP is diagnostic particularly in combination with CT and US. 9 However, in cholangiocellular carcinoma some drawbacks of ERCP are known. 10, 11 As ERCP was non-diagnostic an intrahepatic nature of the icterus was assumed necessitating a histologic diagnosis. A transjugular biopsy was performed because this method has proved to be a useful technique particularly in patients after BMT 12 because of minimising the bleeding hazard due to thrombocytopenia. 13 Unfortunately, in this case liver biopsy was non-diagnostic as well.
After transplantation the patient remained aplastic. Particularly in patients with AML a delayed engraftment can occur after BMT with purged autologous marrow.
14 As the CRP remained at least about 5 mg/100 ml after the initial rise, despite high-dose antibiotic treatment, infection might have contributed to the graft failure.
Finally, at autopsy the diagnosis of a bile duct carcinoma at the porta hepatis (so called Klatskin tumour) could be established, thus explaining the severe cholestasis. The multiple non-invasive and invasive diagnostic procedures had not led to a diagnosis. However, as more therapeutic options are available in severe VOD, [2] [3] [4] [5] it is important to obtain a correct diagnosis, 15 even by procedures that carry a certain risk of complications. Although transjugular liver biopsy is a safe procedure 15 it cannot be excluded that it was accompanied by bacteriaemia which contributed to the fatal sepsis syndrome in our case.
Retrospectively, in this case the focal nature and portal localisation of the bile duct carcinoma weakened the diagnostic abilities of a blind transjugular biopsy. No imaging method had been able to visualise the tumour. This case shows that icterus following BMT remains a diagnostic challenge with sometimes surprising final diagnoses. 16 
